Screening of xenobiotics for direct immunotoxicity in an animal study

Methods

Volumn 41, Issue 1, 2007, Pages 3-8

  De Jong, Wim H ^a   Van Loveren, Henk ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Animal model; Direct immunotoxicity; Immunosuppression; Immunotoxicology

Indexed keywords

XENOBIOTIC AGENT;

ARTICLE; AUTOIMMUNITY; BLOOD; BONE MARROW; CARCINOGENESIS; CELL COMPOSITION; DISEASE SEVERITY; EVALUATION; FOLLOW UP; HISTOPATHOLOGY; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO CULTURE; IN VIVO STUDY; LYMPH NODE; MORBIDITY; MORTALITY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SCREENING; SPLEEN; THYMUS;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSION; TOXICITY TESTS; XENOBIOTICS;

ANIMALIA;

EID: 33845229148     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2006.09.003     Document Type: Article

References (57)

1. Vos J.G. CRC Crit. Rev. Toxicol. 5 (1977) 67-101
2. International Programme on Chemical Safety, Environmental Health Criteria 180 (1996) WHO, Geneva.
3. OECD, Paris, 1995.
4. Putman E., Van Der Laan J.W., and Van Loveren H. Fundam. Clin. Pharmacol. 17 (2003) 615-626
5. Slob W. Toxicol. Sci. 66 (2002) 298-312
6. Travis K.Z., Pate I., and Welsh Z.K. Regulat. Toxicol. Pharmacol. 43 (2005) 280-291
7. Starr T.B., Goodman J.I., and Hoel D.G. Regulat. Toxicol. Pharmacol. 42 (2005) 1-2
8. Lawrence D., Mudzinski S., Rudofsky U., and Warner A. In: Berlin A., Dean J., Draper M.H., and Spreafico F. (Eds). Immunotoxicology (1987), Martinus Nijhoff, Dordrecht 293-307
9. Silbergeld E.K., Silva I.A., and Nyland J.F. Toxicol. Appl. Pharmacol. 207 (2005) 282-292
10. Moszczynski P. Int. J. Occup. Med. Environ. Health 10 (1997) 247-258
11. Vos J.G., Kreeftenberg J.G., Kruijt B.C., Kruizinga W., and Steerenberg P. Clin. Immunol. Immunopathol. 15 (1980) 229-237
12. De Jong W.H., Steerenberg P.A., Ursem P.S., Osterhaus A.D., Vos J.G., and Ruitenberg E.J. Clin. Immunol. Immunopathol. 17 (1980) 63-172
13. Tang H.J., Liu Y.C., Yen M.Y., Chen Y.S., Wann S.R., Lin H.H., Lee S.S., Lin W.R., Huang C.K., Su B.A., Chang P.C., Li C.M., and Tseng H.H. J. Microbiol. Immunol. Infect. 39 (2006) 310-315
14. Bower M., Palmieri C., and Dhillon T. Curr. Opin. Infect. Dis. 19 (2006) 14-19
15. Nagappan V., and Kazanjian P. HIV Clin. Trials 6 (2005) 213-228
16. Kaplan J.E., Hanson D., Dworkin M.S., Frederick T., Bertolli J., Lindegren M.L., Holmberg S., and Jones J.L. Clin. Infect. Dis. 30 Suppl. 1 (2000) S5-S14
17. Tan H.H., and Goh C.L. Am. J. Dermatol. 7 (2006) 13-29
18. Strippoli G.F., Hodson E.M., Jones C., and Craig J.C. Transplantation 81 (2006) 139-145
19. Rowshani A.T., Bemelman F.J., Van Leeuwen E.M., Van Lier R.A., and Ten Berge L.J. Transplantation 79 (2005) 381-386
20. STP Immunotoxicology Working Group. Haley P., Perry R., Ennulat D., Frame S., Johnson C., Lapointe J.-M., Nyska A., Snyder P.W., Walker D., and Walter G. Toxicol. Pathol. 33 (2005) 404-407
21. Schuurman H.-J., Kuper C.F., and Vos J.G. Toxicology 86 (1994) 187-212
22. Kuper C.F., Schuurman H.-J., and Vos J.G. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immuntoxicology vol. 1 (1995), Wiley-Liss, New York 397-436
23. Kuper C.F., De Heer E., Van Loveren H., and Vos J.G. In: Haschek W., Rousseaux C.G., and Wallig M.A. (Eds). Handbook of Toxicologic Pathology. 2nd ed. vol. 2 (2002), Academic Press, San Diego 585-646
24. Gopinath C. Inflamm. Res. 45 Suppl.2 (1996) S74-S78
25. ICICIS Toxicology 125 (1998) 183-201
26. Food and Drug Administration, Washington, USA (1999) .
27. Food and Drug Administration, Washington, USA (2002). .
28. Food and Drug Administration, Washington, USA (2004) .
29. Committee for Proprietary Medicinal Products (2000) .
30. Ruehl-Fehlert C., Bradley A., George C., Germann P.-G., Bolliger A.P., and Schulte A. Exp. Toxicol. Pathol. 57 (2005) 1-5
31. Schulte A., Althoff J., Ewe S., and Richter-Reichhelm H.-B. BGVV Group Investigators. Regulat. Toxicol. Pharm. 36 (2002) 12-21
32. Tilney N. J. Anat. 109 (1971) 369-383
33. Sainte-Marie G., Peng F.-S., and Belisle C. Am. J. Anatomy 164 (1982) 275-309
34. W.H. De Jong, C.F. Kuper, H. Van Loveren, J.G. Vos, Perspect. Exp. Clin. Immunotoxicol., in press.
35. Ward J.M., Uno H., and Frith C.H. Toxicol. Pathol. 21 (1993) 199-205
36. Mitsumori K., Takegawa K., Shimo T., Onodera H., Yasuhara K., and Takahashi M. Arch. Toxicol. 70 (1996) 809-814
37. De Jong W.H., Kroese E.D., Vos J.G., and Van Loveren H. Toxicol. Sci. 50 (1999) 214-220
38. Luster M.I., Portier C., Pait D.G., White Jr. K.L., Gennings C., Munson A.E., and Rosenthal G.J. Fundam. Appl. Toxicol. 18 (1992) 200-210
39. Germolec D.R., Nyska A., Kashon M., Kuper C.F., Portier C., Kommineni C., Johnson K.A., and Luster M.I. Toxicol. Sci. 78 (2004) 107-115
40. Germolec D.R., Kashon M., Nyska A., Kuper C.F., Portier C., Kommineni C., Johnson K.A., and Luster M.I. Toxicol. Sci. 82 (2004) 504-514
41. Basketter D.A., Bremmer J.A., Buckley P., Kammüller M.E., Kawabata T., Kimber I., Loveless S.E., Magda S., Stringer D.A., and Vohr H.-W. Food Chem. Toxicol. 33 (1995) 239-243
42. Putman E., Van Loveren H., Bode G., Dean J., Hastings K., Nakamura K., Verdier F., and Van Der Laan J.W. Drug3 Inform. J. 36 (2002) 417-427
43. Rowley B., and Monestier M. Mol. Immunol. 42 (2005) 833-838
44. Havarinasab S., and Hultman P. Autoimmun. Rev. 4 (2005) 270-275
45. Van Loveren H., Vos J.G., and De Waal E.J. Drug Inform. J. 30 (1996) 179-275
46. Ross P.S., De Swart R.L., Reijnders P.J., Van Loveren H., Vos J.G., and Osterhaus A.D. Environ. Health Perspect. 103 (1995) 162-167
47. Vos J.G., De Klerk A., Krajnc E.I., Kruizinga W., Van Ommen B., and Rozing J. Toxicol. Appl. Pharmacol. 75 (1984) 387-408
48. Vos J.G., Krajnc E.I., and Beekhof P. Environ. Health Perspect. 43 (1982) 115-121
49. Van Loveren H., Verlaan A.P., and Vos J.G. Int. J. Immunopharmacol. 13 (1991) 689-695
50. Houben G.F., Penninks A.H., Seinen W., Vos J.G., and Van Loveren H. Fundam. Appl. Toxicol. 20 (1993) 30-37
51. Smialowicz R.J., Luebke R.W., and Riddle M.M. Toxicology 75 (1992) 235-247
52. Burns L.A., Bradley S.G., White K.L., McCay J.A., Fuchs B.A., Stern M., Brown R.D., Musgrove D.L., Holsapple M.P., and Luster M.I. Drug Chem. Toxicol. 17 (1994) 401-436
53. Burns L.A., White K.L., McCay J.A., Fuchs B.A., Stern M., Brown R.D., Musgrove D.L., Holsapple M.P., Luster M.I., and Bradley S.G. Drug Chem. Toxicol. 17 (1994) 359-399
54. Roth D.R., Roman D., Ulrich P., Mahl A., Junker U., and Perentes E. Exp. Toxicol. Pathol. 57 (2006) 367-371
55. Karrrow N.A., Guo T.L., Zhang L.X., McCay J.A., Musgrove D.L., Peachee V.L., Germolec D.R., and White Jr. K.L. Int. Immunopharmacol. 3 (2003) 1447-1456
56. Holsapple M.P., White Jr. K.L., McCay J.A., Bradley S.G., and Munson A.E. Fundam. Appl. Toxicol. 10 (1988) 701-716
57. Van Loveren H., Vos J.G., Germolec D., Simeonova P.P., Eijkemanns G., and McMichael A.J. Int. J. Hyg. Environ. Health 203 (2001) 483-495